BIOL - BIOLASE, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

BIOLASE, Inc.

4 Cromwell
Irvine, CA 92618
United States
949-361-1200
http://www.biolase.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees225

Key Executives

NameTitlePayExercisedAge
Mr. Harold C. Flynn Jr.CEO, Pres & Director442.04kN/A52
Mr. Dmitri Boutoussov Ph.D.VP of R&D286.2kN/A54
Mr. John R. BeaverSr. VP & CFON/AN/A56
Mr. Richard R. WhippVP of OperationsN/AN/A65
Mr. William E. Brown Jr.VP of Bus. Devel.N/AN/A69
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications. The company also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. Its dental imaging products comprise 3Shape Trios intraoral scanner and digital impression systems for high-speed digital 3-D picture taking; Galaxy BioMill CAD/CAM system that enables dental practitioners to design, scan, mill, and finish crowns, inlays, and veneers inside the dental office; and CEFLA NewTom VGi and VG3 3-D cone beam computed tomography devices. In addition, the company manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. It sells its products primarily to dentists in general practice through its field sales force and distributor network. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.

Corporate Governance

BIOLASE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.